Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 114-117

  Kim, S Y ^a   Choi, H B ^a   Yoon, H Y ^a   Choi, E J ^a   Cho, B ^a   Kim, H K ^a   Kim, Y J ^a   Kim, H J ^a   Min, C K ^a   Kim, D W ^a   Lee, J W ^a   Min, W S ^a   Kim, C C ^a   Kim, T G ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Graft vs host disease; Killer cell immunoglobulin like receptor; Unrelated hematopoietic stem cell transplantation

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACUTE DISEASE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; KOREA; LEUKEMIA; RECEPTORS, IMMUNOLOGIC; TISSUE DONORS;

EID: 34247224459     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.762_9.x     Document Type: Conference Paper

References (12)

1. Bishara A, De Santis D, Witt CC et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004: 63: 204-11.
2. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002: 100: 1935-47.
3. Davies SM, Ruggieri L, DeFor T et al. An evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002: 10: 1182.
4. Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003: 102: 814-9.
5. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002: 295: 2097-100.
6. Bishara A, De Santis D, Witt CC et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004: 63: 204-11.
7. Parham P. Immunogenetics of cell immunoglobulin-like receptors. Mol Immunol 2005: 42: 459-62.
8. Yawata M, Yawata N, McQueen KL et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 2002: 54: 543-50.
9. Verheyden S, Schots R, Duquet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005: 19: 1446-51.
10. Giebel S, Nowak I, Wojnar J et al. Impact of Activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. Transplant Proc 2006: 38: 287-91.
11. De Santis D, Bishara A, Witt CS et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 2005: 65: 519-28.
12. Gagne K, Brizard G, Gueglio B et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002: 63: 271-80.